Search - tctmd.com

Displaying 401 - 420 of 482

Sort: Relevancy | Date

Presentation TCT 2016

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen

November 01, 2016

Presentation TCT 2016

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Philip Green

October 31, 2016

Presentation TCT 2016

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

Presenter: Lutz Buellesfeld, Raj Makkar, Ian T. Meredith

October 31, 2016

News Daily News

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

Todd Neale

September 29, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

News Conference News PCR London Valves 2016

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

Shelley Wood

September 19, 2016

News Daily News

Elderly Asymptomatic Patients With Severe AS Are Often Treated Too Late

L.A. McKeown

September 16, 2016

News Daily News

大型登记表显示 TAVR 后感染性心内膜炎后与糖尿病，残余主动脉瓣关闭不全相关

Yael L. Maxwell

September 14, 2016

News Daily News

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

Yael L. Maxwell

September 14, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Daily News

CMR Confirms Link Between Moderate Aortic Regurgitation Post-TAVR and Poor Outcomes, Mortality

Yael L. Maxwell

August 05, 2016

News Daily News

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Todd Neale

August 01, 2016

News Daily News

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

Shelley Wood

July 20, 2016

News Daily News

Combining Off-Pump CABG and Transaortic TAVR May Be an Option in Some Cases

Todd Neale

July 14, 2016

News Daily News

First Published Report From MAC Global Registry Highlights Risks, Opportunities for Transcatheter Mitral Valve Replacement

Shelley Wood

July 11, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Daily News

Persistent Low-Flow Aortic Stenosis After TAVR Linked With Higher 1-Year Mortality

Michael O'Riordan

June 23, 2016

News Conference News TVT 2016

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

Shelley Wood

June 20, 2016

Advertisement

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

Elderly Asymptomatic Patients With Severe AS Are Often Treated Too Late

大型登记表显示 TAVR 后感染性心内膜炎后与糖尿病，残余主动脉瓣关闭不全相关

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

CMR Confirms Link Between Moderate Aortic Regurgitation Post-TAVR and Poor Outcomes, Mortality

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

Combining Off-Pump CABG and Transaortic TAVR May Be an Option in Some Cases

First Published Report From MAC Global Registry Highlights Risks, Opportunities for Transcatheter Mitral Valve Replacement

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Persistent Low-Flow Aortic Stenosis After TAVR Linked With Higher 1-Year Mortality

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content